Johns Hopkins Medicine researchers continue their exploration into psychedelics and how these drugs may produce a wide range of profound changes in perception, cognition and mood.
In a recent study, published on Nov. 1 in the Journal of Psychopharmacology, experts from the Johns Hopkins Center for Psychedelic and Consciousness Research explored belief changes related to psychedelic experiences.
They found that a single psychedelic experience increased a range of nonphysicalist beliefs as well as beliefs about consciousness, meaning and purpose.
Read more
Psychedelic drugs may reopen critical learning periods in the brain.
Recent research shows that in adult mice, psychedelic drugs including LSD, ketamine and psilocybin have been shown to reopen the brain to a critical window for social learning usually only seen in adolescents.
Read more
Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.
Read more
Reports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.
Read more
Psychedelic drugs can induce mind-altering states affecting perception, thought and sensory input.
They have historically been known for their recreational use and do not have nationwide legal approval.
However, psychedelic drugs are also increasingly being studied for their medical benefits (particularly with regard to mental health).
Learn more below about how certain psychedelics can—and cannot—be used for mental wellness.
Read more
5-MeO-DMT is less commonly known compared to psilocybin and LSD.
But recently it has been gaining more attention as a therapeutic agent. 5-MeO-DMT creates one of the most powerful psychedelic experiences of any substance known.
Can it be used safely and what are the risks?
Read more
Could psychedelics make you more creative? Shift your mind, connect you to others, and help you access a younger, more malleable version of yourself? Activist Rick Doblin, neuroscientist Gül Dölen, and musician Reggie Watts join Brian Greene for a mind-bending and multidisciplinary conversation about the promises and pitfalls of these "magic" molecules and their impact on creativity, connection, and consciousness.
This program is part of the Big Ideas series, supported by the John Templeton Foundation.
Read more
There is still no definitive evidence that microdosing with psychedelics is either effective or safe. Keep reading to read the potential benefits and risks.
Read more